APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nonerosive Reflux Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nonerosive Reflux Disease Treatment Industry Growth and Trends Forecast to 2032

Report ID 174017780119 December 202588 pages

Choose your research edition.

Industry ResearchNonerosive Reflux Disease Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonerosive Reflux Disease Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Nonerosive Reflux Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonerosive Reflux Disease Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonerosive Reflux Disease Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Nonerosive Reflux Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nonerosive Reflux Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nonerosive Reflux Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nonerosive Reflux Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nonerosive Reflux Disease Treatment market include Takeda Pharmaceutical, Eisai, Johnson & Johnson, GlaxoSmithKline, AstraZeneca, SRS Pharmaceuticals, SFJ Pharmaceuticals Group, Ironwood Pharmaceuticals and Daewoong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nonerosive Reflux Disease Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nonerosive Reflux Disease Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nonerosive Reflux Disease Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nonerosive Reflux Disease Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nonerosive Reflux Disease Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nonerosive Reflux Disease Treatment Market by Company

Takeda Pharmaceutical

Eisai

Johnson & Johnson

GlaxoSmithKline

AstraZeneca

SRS Pharmaceuticals

SFJ Pharmaceuticals Group

Ironwood Pharmaceuticals

Daewoong Pharmaceutical

Nonerosive Reflux Disease Treatment Segment by Type

H2 Receptor Antagonists

Antacids

Proton pump inhibitors

Others

Nonerosive Reflux Disease Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Nonerosive Reflux Disease Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonerosive Reflux Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonerosive Reflux Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonerosive Reflux Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nonerosive Reflux Disease Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nonerosive Reflux Disease Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nonerosive Reflux Disease Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nonerosive Reflux Disease Treatment Market Share by Region (2021-2026) Table 4. Global Nonerosive Reflux Disease Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nonerosive Reflux Disease Treatment Market Share by Region (2027-2032) Table 6. Global Nonerosive Reflux Disease Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nonerosive Reflux Disease Treatment Market Size Share by Type (2021-2026) Table 9. Global Nonerosive Reflux Disease Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nonerosive Reflux Disease Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nonerosive Reflux Disease Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nonerosive Reflux Disease Treatment Market Size Share by Application (2021-2026) Table 24. Global Nonerosive Reflux Disease Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nonerosive Reflux Disease Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nonerosive Reflux Disease Treatment Industry Trends Table 37. Nonerosive Reflux Disease Treatment Industry Drivers Table 38. Nonerosive Reflux Disease Treatment Industry Opportunities and Challenges Table 39. Nonerosive Reflux Disease Treatment Industry Restraints Table 40. Global Nonerosive Reflux Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Nonerosive Reflux Disease Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nonerosive Reflux Disease Treatment Key Company Headquarters & Area Served Table 44. Global Nonerosive Reflux Disease Treatment Company, Product Type & Application Table 45. Global Nonerosive Reflux Disease Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nonerosive Reflux Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Company Information Table 49. Takeda Pharmaceutical Business Overview Table 50. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio Table 52. Takeda Pharmaceutical Recent Development Table 53. Eisai Company Information Table 54. Eisai Business Overview Table 55. Eisai Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eisai Nonerosive Reflux Disease Treatment Product Portfolio Table 57. Eisai Recent Development Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Nonerosive Reflux Disease Treatment Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Nonerosive Reflux Disease Treatment Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AstraZeneca Nonerosive Reflux Disease Treatment Product Portfolio Table 72. AstraZeneca Recent Development Table 73. SRS Pharmaceuticals Company Information Table 74. SRS Pharmaceuticals Business Overview Table 75. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio Table 77. SRS Pharmaceuticals Recent Development Table 78. SFJ Pharmaceuticals Group Company Information Table 79. SFJ Pharmaceuticals Group Business Overview Table 80. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product Portfolio Table 82. SFJ Pharmaceuticals Group Recent Development Table 83. Ironwood Pharmaceuticals Company Information Table 84. Ironwood Pharmaceuticals Business Overview Table 85. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio Table 87. Ironwood Pharmaceuticals Recent Development Table 88. Daewoong Pharmaceutical Company Information Table 89. Daewoong Pharmaceutical Business Overview Table 90. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio Table 92. Daewoong Pharmaceutical Recent Development Table 93. North America Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Nonerosive Reflux Disease Treatment Market Share by Country (2021-2026) Table 96. North America Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Nonerosive Reflux Disease Treatment Market Share Forecast by Country (2027-2032) Table 98. Europe Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Nonerosive Reflux Disease Treatment Market Share by Country (2021-2026) Table 101. Europe Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Nonerosive Reflux Disease Treatment Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Country (2021-2026) Table 106. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share Forecast by Country (2027-2032) Table 108. Latin America Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Latin America Nonerosive Reflux Disease Treatment Market Share by Country (2021-2026) Table 111. Latin America Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Latin America Nonerosive Reflux Disease Treatment Market Share Forecast by Country (2027-2032) Table 113. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country (2021-2026) Table 116. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share Forecast by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nonerosive Reflux Disease Treatment Product Image Figure 3. Global Nonerosive Reflux Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Nonerosive Reflux Disease Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Nonerosive Reflux Disease Treatment Market Share by Region (2021-2032) Figure 7. North America Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. H2 Receptor Antagonists Image Figure 13. Global H2 Receptor Antagonists Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antacids Image Figure 15. Global Antacids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Proton pump inhibitors Image Figure 17. Global Proton pump inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Nonerosive Reflux Disease Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Nonerosive Reflux Disease Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Nonerosive Reflux Disease Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Nonerosive Reflux Disease Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Nonerosive Reflux Disease Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Share by Type (2021-2032) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Nonerosive Reflux Disease Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Nonerosive Reflux Disease Treatment Market Share by Application 2025 VS 2032 Figure 35. North America Nonerosive Reflux Disease Treatment Market Size Share by Application (2021-2032) Figure 36. Europe Nonerosive Reflux Disease Treatment Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Share by Application (2021-2032) Figure 38. Latin America Nonerosive Reflux Disease Treatment Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Nonerosive Reflux Disease Treatment Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Nonerosive Reflux Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Nonerosive Reflux Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 45. Europe Nonerosive Reflux Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Nonerosive Reflux Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 48. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 51. Latin America Nonerosive Reflux Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Nonerosive Reflux Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 54. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Receptor Antagonists
  • Antacids
  • Proton pump inhibitors
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda Pharmaceutical
  • Eisai
  • Johnson & Johnson
  • GlaxoSmithKline
  • AstraZeneca
  • SRS Pharmaceuticals
  • SFJ Pharmaceuticals Group
  • Ironwood Pharmaceuticals
  • Daewoong Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nonerosive Reflux Disease Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nonerosive Reflux Disease Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Nonerosive Reflux Disease Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Nonerosive Reflux Disease Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nonerosive Reflux Disease Treatment Market Size (2021-2032)
  8. 1.5.1 North America Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Growth Rate (2021-2032)
2 Nonerosive Reflux Disease Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 H2 Receptor Antagonists
  3. 2.1.2 Antacids
  4. 2.1.3 Proton pump inhibitors
  5. 2.1.4 Others
  6. 2.2 Global Nonerosive Reflux Disease Treatment Market Size by Type
  7. 2.2.1 Global Nonerosive Reflux Disease Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Nonerosive Reflux Disease Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Nonerosive Reflux Disease Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Nonerosive Reflux Disease Treatment Market Size by Regions
  11. 2.3.1 North America Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Breakdown by Type (2021-2026)
3 Nonerosive Reflux Disease Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Retail Pharmacies
  5. 3.2 Global Nonerosive Reflux Disease Treatment Market Size by Application
  6. 3.2.1 Global Nonerosive Reflux Disease Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Nonerosive Reflux Disease Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Nonerosive Reflux Disease Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Nonerosive Reflux Disease Treatment Market Size by Regions
  10. 3.3.1 North America Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Nonerosive Reflux Disease Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nonerosive Reflux Disease Treatment Industry Trends
  2. 4.2 Nonerosive Reflux Disease Treatment Industry Drivers
  3. 4.3 Nonerosive Reflux Disease Treatment Industry Opportunities and Challenges
  4. 4.4 Nonerosive Reflux Disease Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nonerosive Reflux Disease Treatment Revenue (2021-2026)
  2. 5.2 Global Nonerosive Reflux Disease Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nonerosive Reflux Disease Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Nonerosive Reflux Disease Treatment Company, Product Type & Application
  5. 5.5 Global Nonerosive Reflux Disease Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nonerosive Reflux Disease Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nonerosive Reflux Disease Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nonerosive Reflux Disease Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Nonerosive Reflux Disease Treatment Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Nonerosive Reflux Disease Treatment Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Nonerosive Reflux Disease Treatment Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Nonerosive Reflux Disease Treatment Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 SRS Pharmaceuticals
  32. 6.6.1 SRS Pharmaceuticals Company Information
  33. 6.6.2 SRS Pharmaceuticals Business Overview
  34. 6.6.3 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio
  36. 6.6.5 SRS Pharmaceuticals Recent Developments
  37. 6.7 SFJ Pharmaceuticals Group
  38. 6.7.1 SFJ Pharmaceuticals Group Company Information
  39. 6.7.2 SFJ Pharmaceuticals Group Business Overview
  40. 6.7.3 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product Portfolio
  42. 6.7.5 SFJ Pharmaceuticals Group Recent Developments
  43. 6.8 Ironwood Pharmaceuticals
  44. 6.8.1 Ironwood Pharmaceuticals Company Information
  45. 6.8.2 Ironwood Pharmaceuticals Business Overview
  46. 6.8.3 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio
  48. 6.8.5 Ironwood Pharmaceuticals Recent Developments
  49. 6.9 Daewoong Pharmaceutical
  50. 6.9.1 Daewoong Pharmaceutical Company Information
  51. 6.9.2 Daewoong Pharmaceutical Business Overview
  52. 6.9.3 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio
  54. 6.9.5 Daewoong Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst